ClinicalTrials.gg

Bayer clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,694 studies whose lead sponsor is Bayer or one of 4 companies grouped under it. 60 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 5 registry names, not the registry’s. See them and correct one ↓

Compare Bayer with CSPC Pharmaceutical Group and AstraZeneca →

Pipeline: 21 programs

Each counted once: 21 with a study Bayer leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Bayer’s own registered studies; Bayer’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Bayer’s studies test, most open studies first — 169 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 169; every drug is on its own page, and each page lists its sponsors.

Coming up

35 of Bayer’s studies under way reach primary completion within a year, 3 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 2N’26
  2. 4D
  3. 3J’27
  4. F
  5. 4M
  6. 4A
  7. 3M
  8. 3J
  9. 2J
  10. 2A
  11. 4S
  12. 2O
  13. 2N

The 12 nearest

Show 7 more

Add all 35 to your calendar (.ics) → With an account.

All 1,694 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now604%Recruiting 48 · Not yet recruiting 10 · Enrolling by invitation 2
  • Under way, not recruiting372%
  • Completed1,45886%
  • Stopped early1298%Terminated 101 · Withdrawn 28
  • Status unknown or other101%No longer available 8 · Approved for marketing 1 · Available 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 14715
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 3026

By the year each study started; 237 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Bayer.

  • Bayer
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1,674 studies
  • AskBio Inc
    Acquired — became part of Bayer, Dec 1, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Vividion Therapeutics, Inc.
    Acquired — became part of Bayer, Aug 19, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • BlueRock Therapeutics
    Acquired — became part of Bayer, Sep 20, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • AskBio France, SAS, a subsidiary of AskBio Inc.
    Acquired — became part of Bayer, Dec 1, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Bayer leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 46 areas

Studies

Recruiting first, then most recently updated. Showing 50 of 1,694. Browse all 1,694 →